By 2026, the scientific community has moved beyond the static limitations of the genome to focus on the dynamic "Proteome." The Proteomics Market has become the definitive frontier for understanding disease at the functional level. While genomics provides the blueprint, proteomics reveals the actual structural execution of biological processes, enabling a new era of therapeutic...